glp 1 fda issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Approves First Generic GLP-1

Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC

10.1093/hmg/ddu493 387 ZhangY.BurberryA.WangJ

To secure GLP-1s in the final mile of delivery, drivers receive specialized training and extra security measures are in place to track vehicles and secure packages while in transit

March 2024 : The US FDA approved a label expansion for WEGOVY based on a supplemental New Drug Application (sNDA) for the indication of reducing risks of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack (myocardial infarction), or non-fatal stroke in adults with either overweight or obesity and established CVD

Nuclear phosphorylated c-Jun N-terminal kinase (JNK) in HSCs triggers Hedgehog production, which promotes regeneration via GLI1-mediated Cyclin D1 expression after ALPPS